Skip to Content
Morningstar

Lazard Managed Equity Volatility Instl MEVIX

Morningstar Medalist Rating
Medalist Rating as of | See Lazard Investment Hub
  • NAV / 1-Day Return 12.63  /  +0.16 %
  • Total Assets 17.0 Mil
  • Adj. Expense Ratio
    0.750%
  • Expense Ratio 0.750%
  • Distribution Fee Level Below Average
  • Share Class Type Institutional
  • Category Global Large-Stock Blend
  • Investment Style Large Blend
  • Min. Initial Investment 10,000
  • Status Open
  • TTM Yield 2.61%
  • Turnover 83%

USD | NAV as of Apr 19, 2024 | 1-Day Return as of Apr 19, 2024, 10:18 PM GMT+0

Morningstar’s Analysis MEVIX

Will MEVIX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable MEVIX’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the MEVIX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of MEVIX’s parent organization’s priorities and whether they’re in line with investors’ interests.

Lazard Managed Equity Volatility Instl's Average People Pillar and Process Pillar ratings result in a Morningstar Medalist Rating of Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the second-lowest fee quintile among peers.

by Morningstar Manager Research
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings MEVIX

More MEVIX Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 14.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Bristol-Myers Squibb Co

1.58 284,057
Healthcare

Colgate-Palmolive Co

1.54 276,634
Consumer Defensive

NewMarket Corp

1.50 269,714
Basic Materials

Gilead Sciences Inc

1.48 265,751
Healthcare

Procter & Gamble Co

1.44 259,762
Consumer Defensive

Kimberly-Clark Corp

1.42 256,242
Consumer Defensive

Roche Holding AG

1.41 253,235
Healthcare

PepsiCo Inc

1.34 240,989
Consumer Defensive

Japan Post Holdings Co Ltd

1.33 239,574
Financial Services

Merck & Co Inc

1.31 235,003
Healthcare